CorMedix (CRMD) Cash from Financing Activities (2012 - 2025)

CorMedix (CRMD) has 13 years of Cash from Financing Activities data on file, last reported at -$1.4 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities fell 112.52% year-over-year to -$1.4 million; the trailing twelve-month figure through Dec 2025 stood at $238.5 million (up 806.01% YoY), and the FY2025 full-year result was $238.5 million, up 806.01% from the prior year.
• Cash from Financing Activities eased to -$1.4 million in Q4 2025, from $150.5 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $150.5 million in Q3 2025 to a low of -$1.4 million in Q4 2025.
• A 5-year average of $21.1 million and a median of $6.1 million in 2022 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities soared 9710.09% in 2023 and plunged 112.52% in 2025, its largest moves.
• Tracing CRMD's Cash from Financing Activities over 5 years: stood at $176992.0 in 2021, then jumped by 3315.74% to $6.0 million in 2022, then plunged by 92.26% to $467650.0 in 2023, then surged by 2313.18% to $11.3 million in 2024, then slumped by 112.52% to -$1.4 million in 2025.
• Business Quant data shows CRMD's Cash from Financing Activities at -$1.4 million in Q4 2025, $150.5 million in Q3 2025, and $83.2 million in Q2 2025.